Gene Editing Market to grow at 14% CAGR from 2016 to 2024

Gene Editing Market size is driven by rising number of biotechnology and pharmaceutical firms that will provide heavy revenue generating opportunities. Moreover, increasing prevalence of cancer and genetic disorders will further enhance the scope of the gene editing market. Gene editing market is slated to register a massive double-digit growth rate over the coming seven years. According to Global Market Insights, Inc. “Global gene editing market size worth USD 2.17 billion in 2015, is estimated to witness a CAGR of 14% over the period of 2016-2024.”

The rapid technological advancements in healthcare industry will also build a profitable roadmap for the gene-editing industry. Precision medicine market, which is estimated to surpass a revenue of USD 85 billion by 2023, will also promote the gene-industry market trends. The government support and increasing investments in R&D to enhance the technological outlook will also boost the gene editing industry share notably over the coming timeframe. The pharmaceutical industry is also actively collaborating with the gene editing firms to implement the technology use in clinical development. In addition to this, the industry will gain wide acceptance on account of its benefits in the wellbeing of humans, animals, and plant ecosystems.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/810

Gene editing industry finds a varied set of applications across areas such as oncology, muscular disorders, infectious disease, and hematology. Hematology led the application landscape with a revenue of USD 807 million in 2015. Rising prevalence of infectious diseases such as HIV will promote the gene editing industry size in infectious disease applications, with a revenue estimation of USD 2.5 billion by 2024. Moreover, oncology applications will also exhibit a decent growth rate over the coming seven years, with an annual CAGR of 16% over 2016-2024. The increasing number and types of cancer will primarily contribute towards the application growth.

CRISPR/Cas9 is the most prominent technology implemented in the gene editing applications and has been the most buzzed topic among the researchers worldwide. The ability of CRISPR/Cas9 technology to enable multiple edits at once has made it a breakthrough in the gene editing technology landscape. Moreover, its simplicity, specificity, and speed will further promote the technology demand over the coming years. CRISPR technology based gene editing market is estimated to exceed a revenue of USD 3 billion by 2024. Other notable technologies deployed in the gene editing industry include TALENS, Mega nucleases, and Zinc Finger Nucleases (ZFNs).

The major end-users participating in the gene editing market include CROs (Contract Research Organizations), Biotech & Pharma companies, and Research Institutes. Biotech and Pharma dominated the end user landscape accounting for 58% of the overall market share in 2015. The growth can be attributed to increasing applications of gene editing in therapeutics and drug discovery. Moreover, enhancements in the field of genetic engineering will further expand the scope of gene editing market in biotech and pharma sector. CROs will also emerge as a prominent revenue generating sector due to increased outsourcing by the pharmaceutical companies for complex drug discovery.

To access sample pages or view this report titled, “Gene Editing Market Size By Technology (CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), Meganucleases, TALENS), By Application (Hematology, Infectious Disease, Oncology, Muscular Disorders), By End User (Biotech and Pharma, CRO, Research Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Spain, Russia, Poland, China, Japan, India, Australia, Malaysia, Mexico, Brazil, Argentina, South Africa, Saudi Arabia, Israel), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024” in detail along with the table of contents, please click on the link below:

https://www.gminsights.com/pressrelease/gene-editing-market

Considering the global trends, US gene editing industry led the global landscape, with a revenue of USD 518 million in 2015. The trend is likely to continue with the rapid expansion of biotech and pharma industry coupled with the rising prevalence of diseases such as Alzheimer, cancer, and other infectious ailments. UK gene editing market is anticipated to surpass USD 744 million by 2024, driven by the growing geriatric population base and frequent occurrence of chronic ailments across Europe. Asia Pacific will also exhibit substantial growth over the coming years. Improving healthcare infrastructure, technological developments in the medical space, rising geriatric population base, and favorable government norms will stimulate the APAC market growth.

Lack of awareness about gene-editing may prove to be a roadblock for the market growth. However, the government support towards spreading awareness will undoubtedly improve the future business scenario. The emerging economies will gain a major traction of the industry players to expand the regional base. Key market participants include Agilent Technologies, AstraZeneca, Allele Biotech, Cellectis, Bio Rad, Editas Medicine, CRISPR Therapeutics, Lonza, GE Healthcare Dharmacon, Recombinetics, Inc., Qiagen, Thermo Fisher Scientific, and Sigma-Aldrich.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/810

Table of Contents

1. Methodology and Scope

1.1 Research Methodology

1.1.1 Initial data exploration

1.1.2 Statistical modeling and forecast

1.1.3 Industry insights and validation

1.1.4 Research scope and assumptions

1.2 List of Data Sources

1.2.1 Primary sources

1.2.2 Secondary sources

2. Executive Summary

2.1 Gene Editing industry 360⁰ synopsis, 2013 - 2024

2.1.1 Business trends

2.1.2 Application trends

2.1.3 Technology trends

2.1.4 End User trends

2.1.5 Regional trends

3. Gene Editing Industry Insights

3.1 Industry segmentation

3.2 Industry size and future growth prospects, 2013 – 2024

3.3 Industry ecosystem analysis

3.3.1 Vendor matrix

3.4 Industry dynamics

3.4.1 Growth drivers

3.4.1.1 Increased funding for genetics research

3.4.1.2 Increased R&D expenditure and growth of biotechnology

3.4.1.3 Increasing demand for synthetic genes

3.4.1.4 Growing use of genetically modified technology

3.4.1.5 Technology advancements

3.4.2 Industry pitfalls & challenges

3.4.2.1 Stringent government regulations

3.4.2.2 Dearth of public awareness

3.5 Regulatory trends

3.5.1 U.S.

3.5.2 Europe

3.5.3 China

3.6 Key growth opportunities

3.7 Company market share analysis, 2015

3.7.1 Strategy dashboard

3.8 Porter’s analysis

3.9 PESTEL analysis

Browse Related Reports:

Digital Genome Market Size By Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Prep Instruments), By Application (Microbiology [Biological, Clinical, Industrial], Reproductive & Genetic, Transplantation, Livestock and Agriculture, Forensics, Research and Development), By End-Use (Diagnostics & Forensic Labs, Academic Research Institutes, Hospitals, Bio-pharmaceutical Companies), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, Spain, Russia, France, China, Japan, India, Australia, Argentina, Brazil, Mexico South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024

https://www.gminsights.com/industry-analysis/digital-genome-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Analysis of Esoteric Testing Market applications and companies active in the industry

The latest Esoteric Testing Market analysis and research report talks about major applications of Esoteric Testing, growth of these segments as well as offers insights into companies active in this industry and their information. Global Market Insights, Inc. says Esoteric Testing Market size is set to exceed USD 35 billion by 2024.

Growing demand for genomics and proteomics has led to a marked increase for genetic testing. Genetic testing is gaining popularity over the years due to rising prevalence of complex diseases such as muscular dystrophy, epilepsy, and Alzheimer's disease among others. Moreover, growing adoption of companion diagnostics due to rise in demand for targeted therapies for cancer treatment should also contribute to the esoteric testing market growth.

Request for a sample of this research report - https://www.gminsights.com/request-sample/detail/1922

Implementation of advanced technologies such as bioinformatics and growing lab automation trend are other pivotal factors likely to propel the esoteric testing market growth. Tremendous increase in the use of nucleic acid and protein sequencing as well as rising collaborations between companies and research institutes has led to increased adoption of bioinformatics technology. Use of such advancements has made esoteric testing more efficient and accurate for disease diagnosis.

The shift in trend towards preventive disease management and identification of risk factors in the disease areas of endocrinology, oncology as well as reproduction health in women should further fuel the esoteric testing business growth. There has been an increased awareness among the physicians regarding the benefits of prescribing tests for early disease detection and prevention.

Strict regulatory framework, and unfavorable reimbursement scenario along with dearth of qualified technical personnel to operate specialized esoteric tests may restrain esoteric testing industry expansion during the forecast timeframe.

Browse key industry insights spread across 105 pages with 69 market data tables & 9 figures & charts from this 2017 report Esoteric Testing Market in detail along with the table of contents at:

https://www.gminsights.com/industry-analysis/esoteric-testing-market

Oncology segment is slated to witness lucrative rate owing to increasing prevalence of cancer and introduction of number of esoteric tests such as PTEN/ERG FISH, and UroVysion FISH tests for detection of bladder cancer and assessment of treatment for prostate cancer. Moreover, increasing awareness regarding women reproductive health should also spur the demand for esoteric testing in oncology.

Genomics segment represents another promising area for growth in the coming years citing the dynamics the industry is witnessing. For instance, in May 2017, the U.S. FDA approved Merck’s Keytruda drug to treat cancer based on genetic defects rather than the organ or site of tumor. This has been possible due to availability of genetic testing to identify cancer causing abnormalities leading to an effective treatment plan. Thus esoteric tests in genomics are slated to gain market traction during the forecast period.

Chemiluminescence and ELISA technologies are the largest revenue generators in esoteric testing market owing the benefits offered along with high volume of tests conducted for the areas of infectious diseases and immunology.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1922

Mass spectrometry is another technology which is anticipated to grow at rapid rate due to technological advancements in the field and increased usage of combined technologies such as tandem mass spectrometry and LC/MS in esoteric testing.

Europe esoteric testing market is predominantly driven by countries of Germany and UK. Increasing prevalence of cancer and growing demand for early detection are the major factors contributing to growth of esoteric testing market. Moreover, increased knowledge among the physicians regarding esoteric testing should further augment growth.

Japan was the largest esoteric testing market in Asia Pacific region, followed by China and India in 2016. The countries of China and India are slated to witness rapid growth in the coming years due to presence of large unmet needs in terms of large patient pool of infectious and immunological diseases, rising per capita income and development of healthcare infrastructure.

Prominent industry players include Laboratory Corporation of America, Quest Diagnostics, Opko Health Company, Arup Laboratories, Mayo Medical Laboratories, Myriad Genetics, Genomic Health, Invitae, BioMONTR, ACM Global Laboratories, and Nordic Laboratories. The major strategies adopted by the market players include mergers and acquisitions to expand geographical footprint and product offerings to stay ahead in the competitive market.

Browse Related Reports:

Autoimmune Disease Diagnostics Market Size By Product [Systemic (Rheumatoid Arthritis, Ankylosing Spondylitis, Systemic Lupus Erythematosus (SLE)), Localized], Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, U.K, Japan, China, Brazil) Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2023

https://www.gminsights.com/industry-analysis/autoimmune-disease-diagnostics-market

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com
Web: https://www.gminsights.com
Blog: https://gminsights.wordpress.com
Connect with us: Facebook | Google+ | LinkedIn | Twitter

Genome Editing Market share research by applications and regions for 2017-2024

The global Genome Editing Market share report provides numbers for applications and regional segments of the industry covering historical as well as forecast data for decision makers.

Global Market Insights, Inc. says, Genome editing industry value, worth USD 2.17 billion in 2015, is set to hit USD 7.5 billion by 2024.

Genome editing market revenue is anticipated to witness a notable surge over the years ahead, driven by the escalating occurrence of cancer and other genetic inherited disorders coupled with mounting demand for personalized medicines. Companies have been spending extensively on R&D activities across the pharma & biotech sectors. In addition, the availability of enhanced healthcare facilities and the introduction of new modes of treatment will offer lucrative avenues for the gene editing market players to expand their business.

Request for a sample of this research report - https://www.fractovia.org/request-sample/499

Considering the geographical landscape, U.S. genome editing market, worth USD 518.5 million in 2015, is slated to expand considerably in the future. A strong growth trend displayed by biotechnology and pharmaceutical firms is expected to boost the industry size.

UK genome editing industry is projected to cross a revenue of USD 744 million by 2024, registering a CAGR of 14.9% over 2016-2024. The high occurrence of chronic disorders among the rising old population will propel the industry development. Increasing occurrence of HIV, hemophilia, and sickle cell anemia will spur the growth of South Africa industry.

Japan genome editing market revenue, worth USD 160 million in 2015, is projected to grow at a rate of 15% over the coming timeframe. Improvement in healthcare amenities and favorable government policies to restrict the spread of infectious diseases will push the business expansion.

Browse key industry insights spread across 150 pages with 90 market data tables & 7 figures & charts from this 2017 report Genome Editing Market in detail along with the table of contents at:

https://www.fractovia.org/news/industry-research-report/gene-editing-market

Genome editing finds varied applications in muscular disorders, hematology, oncology, and infectious ailments. Hematology, which contributed USD 807 million towards gene editing industry share in 2015, is expected to make notable contributions towards the industry revenue even in the future. Oncology is set to record a CAGR of 15.9% over the coming seven years, with the mounting occurrence of various kinds of cancers.

Biotech & pharma firms, contract research organizations, and research institutes are the key end-users of genome editing industry. Biotech & pharma sector, which accounted for more than 58% of gene editing market size in 2015, is expected to witness a substantial surge over the next few years. Rising use of the technology in medicines and therapeutics will boost the revenue.

Make an inquiry for purchasing this report @ https://www.fractovia.org/request-purchase/499

Genome editing makes use of technologies such as meganucleases, CRISPR/Cas9, TALENS, and zinc finger nucleases. CRISPR technology, which dominated the overall market in 2015, is set to surpass USD 3 billion by 2024. The growth can be ascribed to wider applications of the technology in farming and genetic engineering.

Bio Rad Laboratories Inc., Editas Medicine, Sigma-Aldrich, Thermo Fisher Scientific, and Allele Biotechnology are the major players of gene editing market.

Browse Related Report:

Digital Genome Market Size By Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Prep Instruments), By Application (Microbiology [Biological, Clinical, Industrial], Reproductive & Genetic, Transplantation, Livestock and Agriculture, Forensics, Research and Development), By End-Use (Diagnostics & Forensic Labs, Academic Research Institutes, Hospitals, Bio-pharmaceutical Companies), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, Spain, Russia, France, China, Japan, India, Australia, Argentina, Brazil, Mexico South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024

https://www.gminsights.com/industry-analysis/digital-genome-market

About Fractovia.org:

Fractovia.org is one of India's leading in-house and free news portal. It is fully automated, and operates on a constant premise, interfacing with news sites and offering redesigned breaking features to readers across the globe. Our mission is to offer individuals opportunities for connections with news writers and distributors which they can pursue. We operate by mapping articles pertaining to breaking news, constantly and progressively, against a pre-determined word-based theme, offering important connections to readers and clients, as well as distributors.

Contact Us:

Arun Hegde
Corporate Sales, USA
Fractovia.org
Phone: 1-302-846-7766
Email: sales@fractovia.org
Web: https://www.fractovia.org
Contact Us: Facebook | Twitter